Integrated Diagnostics - Product Pipeline Analysis

GlobalData, October 2011, Pages: 16

Integrated Diagnostics - Product Pipeline Analysis

Summary

Integrated Diagnostics is engaged in developing diagnostic products and measurement technologies. Its diagnostic products are used by physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer’s through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company develops game changing diagnostic tools and innovative biomarkers to help patients and physicians to detect disease in its earliest stages that is be predictive, preventive, personalized and participatory.

This report is a source for data, analysis and actionable intelligence on the Integrated Diagnostics portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
Key Facts
Integrated Diagnostics - Major Products and Services
Integrated Diagnostics Pipeline Products by Equipment Type
Integrated Diagnostics Pipeline Products by Development Stage
Integrated Diagnostics Pipeline Products by Therapy Area
Diagnostic Test - Alzheimer Disease
Product Status
Product Description
Diagnostic Test - Diabetes
Product Status
Product Description
Diagnostic Test - Lung Cancer
Product Status
Product Description
HIV Diagnostic Device
Product Status
Product Description
Integrated Diagnostics - Key Competitors
Integrated Diagnostics - Key Employees
Integrated Diagnostics - Locations And Subsidiaries
Head Office
Recent Developments
Mar 09, 2011: Integrated Diagnostics Appoints Jay Moyes To Board
Jan 26, 2011: Integrated Diagnostics Appoints Kenneth Fang As Chief Medical Officer
Oct 05, 2010: Integrated Diagnostics Names Gregory Critchfield As Independent Director
Mar 29, 2010: Integrated Diagnostics Appoints Dr. Albert Luderer As CEO
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Integrated Diagnostics, Key Facts
Integrated Diagnostics Key Pipeline Products by Equipment Type
Integrated Diagnostics Key Pipeline Products by Therapy Area
Integrated Diagnostics Key Pipeline Products by Development Stage
Integrated Diagnostics, Key Facts
Integrated Diagnostics Number of Pipeline Products by Equipment Type
Integrated Diagnostics Pipeline Products by Equipment Type
Integrated Diagnostics Number of Pipeline Products by Development Stage
Integrated Diagnostics Pipeline Products by Development Stage
Integrated Diagnostics Number of Pipeline Products by Therapy Area
Integrated Diagnostics Pipeline Products by Therapy Area
Diagnostic Test - Alzheimer Disease - Product Status
Diagnostic Test - Alzheimer Disease - Product Description
Diagnostic Test - Diabetes - Product Status
Diagnostic Test - Diabetes - Product Description
Diagnostic Test - Lung Cancer - Product Status
Diagnostic Test - Lung Cancer - Product Description
HIV Diagnostic Device - Product Status
HIV Diagnostic Device - Product Description
Integrated Diagnostics, Key Employees

List of Figures
Integrated Diagnostics Key Pipeline Products by Equipment Type
Integrated Diagnostics Pipeline Products by Equipment Type
Integrated Diagnostics Pipeline Products by Development Stage
Integrated Diagnostics Pipeline Products by Therapy Area

Zymo Research Corporation
Bionostics, Inc.

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• Northrop Grumman Corporation-Competitive Benchmarking Analysis
• Global Automotive Head-up Display Market 2012-2016
• Supplying Ford 2012
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Rush Enterprises, Inc. (RUSHA) - Financial and Strategic SWOT Analysis Review
• Supplying Chrysler
• TRW Automotive Holdings Corp. (TRW) - Financial and Strategic SWOT Analysis Review